Who is sponsoring NCT06795763?

NCT06795763 is sponsored by Elumn8 Medical.

What drugs are being tested in NCT06795763?

Interventions in NCT06795763: CTO-PCI Procedure with Acolyte Catheter System.

What condition does NCT06795763 study?

NCT06795763 studies Coronary Chronic Total Occlusions, Ischemic Heart Disease, Ischemic Heart Disease (IHD), Ischemic Heart Disease Chronic.

Is NCT06795763 still recruiting?

NCT06795763 is currently enrolling by invitation. Last updated 23 February 2026.

Last reviewed 2026-02-23 · How we verify

NCT06795763

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures

ENROLLING BY INVITATION NA Last updated 23 February 2026

What this trial tests

NA trial testing CTO-PCI Procedure with Acolyte Catheter System in Coronary Chronic Total Occlusions in 115 participants. Enrolling by invitation.

Timeline

6 August 2025

Primary endpoint
1 September 2026

1 September 2027

Quick facts

Lead sponsor	Elumn8 Medical
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	115
Start date	6 August 2025
Primary completion	1 September 2026
Estimated completion	1 September 2027
Sites	5 locations across United States

Drugs / interventions tested

CTO-PCI Procedure with Acolyte Catheter System

Conditions studied

Coronary Chronic Total Occlusions — all drugs for Coronary Chronic Total Occlusions →
Ischemic Heart Disease — all drugs for Ischemic Heart Disease →
Ischemic Heart Disease (IHD) — all drugs for Ischemic Heart Disease (IHD) →
Ischemic Heart Disease Chronic — all drugs for Ischemic Heart Disease Chronic →

Sponsor

Elumn8 Medical

Who can join

18 and older, any sex, with Coronary Chronic Total Occlusions or Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study to evaluate the safety and effectiveness of the Acolyte Catheter System used in CTO-PCI procedures. The system will be used for the placement and positioning of guidewires and catheters in the coronary vasculature for the treatment of patients with coronary chronic total occlusions with persistent symptoms following medical therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Chronic Total Occlusions

Currently open trials in the same condition.

NCT06957613 — The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06795763 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Elumn8 Medical
Last refreshed: 23 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06795763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing